Follow
Rahul Parikh
Rahul Parikh
Rutgers Cancer Institute of New Jersey
Verified email at cinj.rutgers.edu
Title
Cited by
Cited by
Year
Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the International Lymphoma Radiation Oncology Group
RW Tsang, BA Campbell, JS Goda, CR Kelsey, YM Kirova, RR Parikh, ...
International Journal of Radiation Oncology* Biology* Physics 101 (4), 794-808, 2018
1632018
Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation
RR Parikh, BG Haffty, D Lannin, MS Moran
International Journal of Radiation Oncology* Biology* Physics 82 (1), 7-13, 2012
912012
Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression
RR Parikh, Q Yang, SA Higgins, BG Haffty
International Journal of Radiation Oncology* Biology* Physics 70 (1), 35-42, 2008
852008
Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression
RR Parikh, Q Yang, SA Higgins, BG Haffty
International Journal of Radiation Oncology* Biology* Physics 70 (1), 35-42, 2008
852008
Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression
RR Parikh, Q Yang, SA Higgins, BG Haffty
International Journal of Radiation Oncology* Biology* Physics 70 (1), 35-42, 2008
852008
Evidence-based review on the use of proton therapy in lymphoma from the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee
YD Tseng, DJ Cutter, JP Plastaras, RR Parikh, O Cahlon, MD Chuong, ...
International Journal of Radiation Oncology, Biology, Physics 99 (4), 825-842, 2017
782017
Local therapy improves overall survival in patients with newly diagnosed metastatic prostate cancer
RR Parikh, J Byun, S Goyal, IY Kim
The Prostate 77 (6), 559-572, 2017
702017
Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer
RR Parikh, D Housman, Q Yang, D Toppmeyer, LD Wilson, BG Haffty
International Journal of Radiation Oncology* Biology* Physics 72 (4), 1056-1063, 2008
582008
Prognostic significance of vascular endothelial growth factor protein levels in T1‐2 N0 laryngeal cancer treated with primary radiation therapy
RR Parikh, Q Yang, BG Haffty
Cancer: Interdisciplinary International Journal of the American Cancer …, 2007
562007
Prevention of N-Methyl-N-Nitrosourea–Induced Breast Cancer by α-Fetoprotein (AFP)–Derived Peptide, a Peptide Derived from the Active Site of AFP
RR Parikh, N Gildener-Leapman, A Narendran, HY Lin, N Lemanski, ...
Clinical cancer research 11 (23), 8512-8520, 2005
522005
Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy
NK Taunk, S Goyal, MS Moran, Q Yang, R Parikh, BG Haffty
Radiotherapy and Oncology 96 (2), 204-208, 2010
512010
Insurance approval for proton beam therapy and its impact on delays in treatment
A Gupta, AJ Khan, S Goyal, R Millevoi, N Elsebai, SK Jabbour, NJ Yue, ...
International Journal of Radiation Oncology* Biology* Physics 104 (4), 714-723, 2019
482019
Patterns of proton therapy use in pediatric cancer management in 2016: an international survey
N Journy, DJ Indelicato, DR Withrow, T Akimoto, C Alapetite, M Araya, ...
Radiotherapy and Oncology 132, 155-161, 2019
482019
Disparities in survival by insurance status in patients with H odgkin lymphoma
RR Parikh, ML Grossbard, BL Green, LB Harrison, J Yahalom
Cancer 121 (19), 3515-3524, 2015
472015
Early-stage classic Hodgkin lymphoma: The utilization of radiation therapy and its impact on overall survival
RR Parikh, ML Grossbard, LB Harrison, J Yahalom
International Journal of Radiation Oncology* Biology* Physics 93 (3), 684-693, 2015
402015
Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities
RR Parikh, R Rhome, E Hug, H Tsai, O Cahlon, B Chon, A Goenka
Clinical lung cancer 17 (5), 362-366, 2016
392016
Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma
R Rhome, R Fisher, A Hormigo, RR Parikh
Journal of neuro-oncology 128, 241-250, 2016
332016
Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy
RR Parikh, BK Moskowitz, E Maher, D Della Rocca, R Della Rocca, ...
Leukemia & Lymphoma 56 (5), 1266-1270, 2015
332015
Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer
A Srivastava, Z Rivera‐Núñez, S Kim, J Sterling, NJ Farber, KD Radadia, ...
Cancer 126 (13), 2991-3001, 2020
292020
Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma
RR Parikh, ML Grossbard, LB Harrison, J Yahalom
Radiotherapy and Oncology 118 (1), 52-59, 2016
252016
The system can't perform the operation now. Try again later.
Articles 1–20